CardioNerds HCM Knowledge Hub

Welcome to the Hypertrophic Cardiomyopathy (HCM) Knowledge Hub powered by CardioNerds. We deliver key insights and unique perspectives through podcasts, articles, videos and more—all uniquely created by cardiologists to inform and educate.

FDA Approves Mavcamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy

Devesh Rai, MDCardiology | April 17, 2025

The United States Food and Drug Administration (FDA) approved Mavacamten to treat patients with symptomatic obstructive ...

The VALOR-HCM Trial: Encouraging Findings for Patients with Obstructive HCM

CardioNerdsCardiology | April 17, 2025

In this insightful interview, Rawan Amir, MBBS, and CardioNerds Academy Fellow, spoke with Milind Desai, MD, MBA, ...

The Digital Diagnostician: Deep Learning to Detect HCM vs. Amyloidosis

Hirsh ElhenceCardiology | April 17, 2025

As novel therapeutic agents such as Mavacamten and Tafamidis are developed and become clinically useful for patients ...

VALOR-HCM: Mavacamten Decreases Need for Septal Reduction Therapy in Symptomatic Obstructive HCM

CardioNerdsCardiology | April 17, 2025

New pharmacological agent reduces need for septal reduction therapy in patients with symptomatic obstructive ...

Artificial Intelligence Based ECG Scores Can Predict Response to Treatment in Hypertrophic Obstructive, Is This the Future?

Devesh Rai, MDCardiology | April 17, 2025

Historically, early detection of hypertrophic cardiomyopathy (HCM) has been challenging, and prior artificial ...

Podcast 118. The Braunwald Chronicles: A “Royal Screw-up” & The Discovery of Hypertrophic Cardiomyopathy

CardioNerdsCardioNerds | April 17, 2025

CardioNerds (Amit Goyal, Daniel Ambinder, Carine Hamo, and Karan Desai) are honored to bring to you the Braunwald ...